Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
There are no published clinical trial data evaluating this pairing, and it does not exist as a named investigational product or registered trial programme
Indian pharmaceutical firms may explore biosimilars or more affordable versions in the future, but no generic alternatives are available yet
10.1093/humrep/17.5.1257
Overview Tirzepatide 15 mg is the highest therapeutic dose available in compounded dual-pathway weight-loss therapy
Patients with personal or family history of medullary thyroid cancer should avoid both medications, and those with diabetic retinopathy require careful monitoring given potential worsening of vision in rapid glycemic control scenarios
Know the Risks
US$ 24.38
US$ 24.11
US$ 24.46
US$ 26.93
